Search Results
10
Everything
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
March 31, 2025 08:00 ET
|
OKYO Pharma LTD
Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for more than 2½ yearsFDA requires drug to show long-term...
Glimpact Study Quantifies Environmental Impact of Retail TikTok Ads - H&M’s Holiday Campaign Equivalent to Driving One Car Halfway Around the World
March 19, 2025 08:26 ET
|
Glimpact
NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Glimpact, the first platform for analyzing the overall systemic environmental impact of products and organizations, released today their holiday ad...
YPrime Earns Prestigious EcoVadis Rating, Strengthening Commitment to Sustainable and Responsible Clinical Research
March 12, 2025 08:00 ET
|
Y-Prime, LLC
YPrime earns prestigious EcoVadis rating, reinforcing commitment to sustainable clinical research.
Politecnico di Torino flies to Ethiopia for an institutional mission
March 03, 2025 07:01 ET
|
Politecnico di Torino
The Turin’s technical University expands connections and networks with Ethiopia in line with its internationalization strategy, in which Africa is among the leading countries TURIN, Italy, March ...
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
February 25, 2025 08:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
CEOs face personal inflection point affecting decision making, management and culture; seek to recalculate AI journey, CEO study finds
January 21, 2025 08:53 ET
|
The Futurum Group
Davos, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) --CEOs of established enterprises (10 years and up) sense internal paralysis despite owning richer historical data sets while emerging ‘digital...
The BPI Network and Growth Officer Council Launch Study to Examine Major Challenges Around Data AI Readiness
January 14, 2025 08:00 ET
|
CMO Council
Thought Leadership Initiative will Investigate How Prepared and Primed Organizations are to Unlock GenAI’s Next-Generation Business Value
Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
January 10, 2025 08:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 04, 2024 07:30 ET
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
No Evidence that Tampons Cause Metal Poisoning: American College of Medical Toxicology Issues Position Statement
October 14, 2024 15:21 ET
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 14, 2024 (GLOBE NEWSWIRE) -- A recent paper by Shearston et al.,” Tampons as a source of exposure to metal(loid)s,” revealed their testing had detected trace amounts of 16 metals...